Revised SPC: Omnitrope (somatropin) SurePal solution for injection cartridges- all strengths

SPC now warns that although rare, pancreatitis should be considered in somatropin-treated patients who develop abdominal pain, especially in children. Also updated to note that gynaecomastia (uncommon frequency) has been reported in post-marketing studies.

Source:

electronic Medicines compendium